Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.1.347NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.195NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.321NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.379NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.78NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.16NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.231NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.49NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.67NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.190NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.133NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.18NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.466NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.489NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.363NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.95NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.36.26NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.531NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.45NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.200NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BF.35NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
CY.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
FR.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBJ.4NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
CP.7NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
GJ.1.2.3NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
CK.1.1.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.2.56.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BF.7.21NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BF.7.13.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BF.37NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.120NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
AM.3NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
AA.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.249NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
AA.3NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.505NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.74NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-1906.48Singapore
B.1.406NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.115NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.29NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
AA.8NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.178NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.208NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.197NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.491NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-2491.68Singapore
EV.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
P.1.8 (Gamma)NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
AY.39.3 (Delta)NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BQ.1.8.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used